Biomerica (BMRA) Executive Vice Chairman Allen Barbieri Buys Stock

What Happened
Allen Barbieri, Executive Vice Chairman and Director of Biomerica, acquired 20,000 shares of the company's common stock on August 26, 2026. The purchase price was $1.60 per share, for a total consideration of $32,000. This was a purchase (transaction code P) — an insider buy rather than a sale.

Key Details

• Transaction date: August 26, 2026; Form 4 filed August 27, 2026 (timely filing).
• Shares acquired: 20,000 at $1.60 per share; total purchase $32,000.
• Transaction type: Private placement (per footnote), not an open-market trade.
• Shares owned after transaction: Not specified in the filing.
• Notable footnote: Acquisition made under a Securities Purchase Agreement dated August 20, 2026, involving certain institutional and individual investors (including B. Riley Principal Capital, LLC and some board members/executive officers).
• No indication of option exercise, gift, tax withholding, or a 10b5-1 plan in this filing.

Context
This was a direct purchase in a private placement alongside institutional and other investor participants, which differentiates it from routine open-market buys. Insider purchases can be more informative to investors than sales, but they do not guarantee future performance. The filing appears timely (filed the day after the transaction).